cosciensbio.com (CSCI) Quarterly EPS earnings growth

Symbol and logo of brand COSCIENS Bio (CSCI)

COSCIENS Biopharma Inc. relies on exclusive innovation rights and the global distribution of orphan drugs. The scaling model is based on licensing formulas for royalties without incurring plant costs. The company is currently expanding sales through oncology developments. The quarterly EPS growth efficiency metric demonstrates current profit dynamics, where -31.20 determines the current value of the indicator.

CSCI: COSCIENS Biopharma Year-over-year earnings per one share growth for the last 12 months 08/10/2024 - 09/14/2025

COSCIENS Bio (CSCI) - metric breakdowns and financial figures

- share price and expert price forecast:
Stock Price COSCIENS Biopharma|CSCI - Average Forecast Price
- market capitalization details:
Market Capitalization Aeterna Zentaris|CSCI - Business Value
- balance sheet net asset value indicators:
Accounting Value per Share COSCIENS Biopharma|CSCI - Accounting Value of Company|Market Value to Book Value Ratio cosciensbio.com|CSCI - Total Asset Value of Company
- debt and solvency information:
Total Debt to Capital COSCIENS Biopharma Inc.|CSCI - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital COSCIENS Biopharma Inc.|CSCI - Company Aggregate Debts|Debt to Book Capitalization Ratio Aeterna Zentaris|CSCI - Company Long-Term Loans and Borrowings|Company Short-Term Debt COSCIENS Biopharma|Quick Ratio cosciensbio.com
- earnings and valuation multiples information:
CSCI - Net Profit|Projected Future Earnings COSCIENS Biopharma Inc.|CSCI - Price to Earnings Ratio|Future Price to Earnings Aeterna Zentaris|CSCI - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Aeterna Zentaris|CSCI - Operating income before deduction of amortization|Net earnings per share (EPS TTM) COSCIENS Biopharma|CSCI - Net earnings per share for the last 12 months|Quarterly EPS earnings growth cosciensbio.com|CSCI - Expected net earnings per share growth this year|Earnings growth forecast for next year COSCIENS Biopharma Inc.
Initial company analysis:COSCIENS Biopharma Inc.
Flagship merchandise of COSCIENS Bio

This indicator measures the quarterly dynamics of earnings per share, allowing for the exclusion of one-time accounting adjustments to assess the actual efficiency of capital management. An analysis of the quarterly EPS growth for COSCIENS Biopharma Inc. (CSCI) reflects the extent to which the diversification of its orphan drug pipeline converts into financial results, confirming the long-term sustainability of the business model in the US and European markets.

Who COSCIENS Biopharma Inc. competes with

VRTX: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Alnylam Pharmaceuticals, Inc. (ALNY)|INSM (Insmed Inc) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months UTHR (United Therapeutics Inc.)|Year-over-year net earnings per share growth for the last 12 months BMRN (BioMarin Pharmaceutical)|BBIO (bridgebio.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months BGM Group BGM|COGT (Cogent Biosciences Inc) - Year-over-year net earnings per share trend for the last twelve months|Xeris Biopharma Inc - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months KROS (Keros Corp)|ARCT: Quarterly EPS earnings growth|etonpharma.com (ETON) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Kamada|FULC: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Abeona Therapeutics (ABEO)|Year-over-year net earnings per share growth for the last 12 months mereobiopharma.com MREO|Quarterly EPS earnings growth PLX (Protalix BioTherapeutics)|Quarterly EPS earnings growth Pliant Therapeutics Inc PLRX|Applied Therapeutics - Quarterly EPS earnings growth|Rein Therapeutics Inc. (RNTX) - Year-over-year net earnings per share growth for the last 12 months|gelteq.com (GELS) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Aytu BioPharma (AYTU)|Year-over-year earnings per share growth for the last twelve months Chemomab Therapeutics Ltd|SRx Health (SRXH) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth PLRZ|Year-over-year net earnings per share growth for the last 12 months zentaris.com AEZS|Quarterly EPS earnings growth CYTH (CTD Holdings)|Year-over-year net earnings per share change for the last twelve months Inozyme Pharma Inc. (INZY)|Reneo Pharmaceuticals - Quarterly EPS earnings growth